Zydus Receives Final Approval from USFDA for Clobetasol Propionate Cream USP 0.05%

Deepthi | Myequity news | Date : 17-10-2018 15:20:00 IST

Zydus Cadila has received the final approval from USFDA to market Clobetasol Propionate Cream USP 0.05%. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

About Zydus Cadila:

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs nearly 23000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research—based pharmaceutical company by 2020

More from Myequity